Drug Resistance, Multiple, Bacterial
"Drug Resistance, Multiple, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Descriptor ID |
D024901
|
MeSH Number(s) |
G06.099.225.812 G06.225.347.812 G07.690.773.984.269.347.812 G07.690.773.984.300.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Multiple, Bacterial".
- Biological Sciences [G]
- Microbiological Phenomena [G06]
- Bacterial Physiological Phenomena [G06.099]
- Drug Resistance, Bacterial [G06.099.225]
- Drug Resistance, Multiple, Bacterial [G06.099.225.812]
- Drug Resistance, Microbial [G06.225]
- Drug Resistance, Bacterial [G06.225.347]
- Drug Resistance, Multiple, Bacterial [G06.225.347.812]
- Physiological Phenomena [G07]
- Pharmacological and Toxicological Phenomena and Processes [G07.690]
- Pharmacological Phenomena [G07.690.773]
- Drug Resistance [G07.690.773.984]
- Drug Resistance, Microbial [G07.690.773.984.269]
- Drug Resistance, Bacterial [G07.690.773.984.269.347]
- Drug Resistance, Multiple, Bacterial [G07.690.773.984.269.347.812]
- Drug Resistance, Multiple [G07.690.773.984.300]
- Drug Resistance, Multiple, Bacterial [G07.690.773.984.300.500]
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Multiple, Bacterial".
This graph shows the total number of publications written about "Drug Resistance, Multiple, Bacterial" by people in this website by year, and whether "Drug Resistance, Multiple, Bacterial" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 | 2005 | 1 | 0 | 1 | 2006 | 0 | 1 | 1 | 2007 | 2 | 1 | 3 | 2008 | 3 | 1 | 4 | 2010 | 4 | 1 | 5 | 2011 | 2 | 2 | 4 | 2014 | 0 | 2 | 2 | 2015 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Resistance, Multiple, Bacterial" by people in Profiles.
-
Stagg HR, Brown J, Ibraim E, Riekstina V, Viiklepp P, Cirule A, Cocei H, Danilovitš M, Dravniece G, Jackson C, White PJ. Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study. PLoS One. 2015; 10(11):e0142425.
-
Bowers DR, Cao H, Zhou J, Ledesma KR, Sun D, Lomovskaya O, Tam VH. Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii. Antimicrob Agents Chemother. 2015 May; 59(5):2720-5.
-
Phe K, Johnson ML, Palmer HR, Tam VH. Validation of a model to predict the risk of nephrotoxicity in patients receiving colistin. Antimicrob Agents Chemother. 2014 Nov; 58(11):6946-8.
-
Abdelraouf K, Chang KT, Yin T, Hu M, Tam VH. Uptake of polymyxin B into renal cells. Antimicrob Agents Chemother. 2014 Jul; 58(7):4200-2.
-
Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy. J Med Assoc Thai. 2011 Jul; 94(7):863-70.
-
Salvatore CM, Abdelraouf K, Hsing DD, Tam VH. Pharmacokinetics of polymyxin B in an infant with multidrug-resistant Klebsiella pneumoniae bacteremia. Pediatr Infect Dis J. 2011 Jun; 30(6):537-9.
-
Abdelraouf K, Kabbara S, Ledesma KR, Poole K, Tam VH. Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa. J Antimicrob Chemother. 2011 Jun; 66(6):1311-7.
-
Hirsch EB, Chang KT, Lasco TM, Caeiro JP, Tam VH. Emergence of KPC-producing Klebsiella pneumoniae in Texas. Diagn Microbiol Infect Dis. 2011 Feb; 69(2):234-5.
-
Hirsch EB, Tam VH. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res. 2010 Aug; 10(4):441-51.
-
Tam VH, Rogers CA, Chang KT, Weston JS, Caeiro JP, Garey KW. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother. 2010 Sep; 54(9):3717-22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|